GENEREX BIOTECHNOLOGY CORP Insider Trading for February 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENEREX BIOTECHNOLOGY CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GENEREX BIOTECHNOLOGY CORP for February 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16 2016 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,667,671 | 1,668 | 0 | |
| Feb 16 2016 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Buy | M | 0.00 | 1,667,671 | 1,668 | 5,615,070 | 3.9 M to 5.6 M (+42.25 %) |
| Feb 16 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Option Exercise | M | 0.00 | 4,447,111 | 4,447 | 0 | |
| Feb 16 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Buy | M | 0.00 | 4,447,111 | 4,447 | 15,821,836 | 11.4 M to 15.8 M (+39.10 %) |
| Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | FELLOWS STEPHEN | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,667,671 | 1,668 | 1,667,671 | |
| Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | Von Hofe Eric | President of Subsid ... | Option Exercise | M | 0.00 | 7,610,911 | 7,611 | 7,610,911 | |
| Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,667,671 | 1,668 | 1,667,671 | |
| Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Option Exercise | M | 0.00 | 845,492 | 845 | 0 | |
| Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Option Exercise | M | 0.00 | 595,239 | 595 | 0 | |
| Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,928,925 | 1,929 | 0 | |
| Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Option Exercise | M | 0.00 | 546,448 | 546 | 0 | |
| Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Buy | M | 0.00 | 5,583,775 | 5,584 | 3,916,104 | -1,667,671 to 3.9 M (-334.82 %) |
| Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Option Exercise | M | 0.00 | 4,447,111 | 4,447 | 4,447,111 | |
| Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Option Exercise | M | 0.00 | 1,587,300 | 1,587 | 0 | |
| Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Option Exercise | M | 0.00 | 5,143,787 | 5,144 | 0 | |
| Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Option Exercise | M | 0.00 | 1,457,195 | 1,457 | 0 | |
| Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Buy | M | 0.00 | 14,890,033 | 14,890 | 10,442,992 | -4,447,041 to 10.4 M (-334.83 %) |